BridgeBio Pharma Inc. (BBIO) Tops Q1 EPS by 3c

BridgeBio Pharma Inc. (NASDAQ: BBIO) reported Q1 EPS of ($0.88), $0.03 better than the analyst estimate of ($0.91). Revenue for the quarter came in at $116.63 million versus the consensus estimate of $54.46 million.

For earnings history and earnings-related data on BridgeBio Pharma Inc. (BBIO) click here.

You May Also Be Interested In

• Chevron signed an agreement with Iraq's Basra Oil Company to advance commercial negotiations for West Qurna 2
• Hims & Hers chief accounting officer to resign in October
• J. M. Smucker (SJM) Raises Quarterly Dividend 1.8% to $1.12; 4% Yield